Controlled release systems and low dose androgens
US5434146A · kind A · utility
121Cited by
8References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 1992 |
| Grant date | Jul 18, 1995 |
| Priority date | — |
| Expiry date | Jun 24, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/2982
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treatment and prevention of estrogen-related diseases, and of fertility control, include low dose (e.g. less than 50 nanomolaR serum concentration) administration of certain anabolic steroids, progestins and other substantially non-masculinizing androgenic compounds. Sustained release formulations substantially free of organic solvent, and sustained release formulations for maintaining low serum levels of androgen are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.